Skip to main content
Watch Insiders
Market intelligence
MAIAHealthcare

MAIA Biotechnology Inc insider activity

In the last 90 days, 3 corporate insiders purchased $203,776 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$203,776
Corporate buyers
3
Latest transaction
Jun 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 1, 2026Vlad VitocChief Executive OfficerOpen Market Purchase72,700$1.39$100,886
Jun 1, 2026Stan SmithCorporate insiderOpen Market Purchase75,000$1.34$100,200
Jun 1, 2026Sergei GryaznovChief Scientific OfficerOpen Market Purchase2,000$1.35$2,690